Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

What 5 Analyst Ratings Have To Say About Open Lending

Over the past 3 months, 5 analysts have published their opinion on Open Lending (NASDAQ:LPRO) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

How Is The Market Feeling About Aveanna Healthcare Holdings Inc. - Common Stock?

Aveanna Healthcare Holdings Inc. - Common Stock's (NASDAQ:AVAH) short percent of float has fallen 9.46% since its last report. The company recently reported that it has 2.38 million shares sold short, which is 5.07% of all regular shares that are available for trading.

Benzinga

How Is The Market Feeling About Dave & Busters Entertainment Inc?

Dave & Busters Entertainment Inc's (NASDAQ:PLAY) short percent of float has fallen 4.41% since its last report. The company recently reported that it has 4.82 million shares sold short, which is 10.19% of all regular shares that are available for trading.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

FAT Brands Expands Johnny Rockets To Israel

FAT Brands Inc (NASDAQ:FAT) owned restaurant brand Johnny Rockets has signed a development deal to expand into Israel with 10 new franchised locations. Franchisee F and J Master License LTD will bring Johnny Rockets to Israel with the restaurants set to open over the next 10 years. "The demand for all-American fare continues…

Benzinga

Why Tesla Stock Could Be Headed For Blue Sky Run If This Key Pattern Forms

Tesla, Inc (NASDAQ: TSLA) opened the trading session slightly lower on Wednesday in consolidation after soaring over 10% between Monday and Tuesday.

Benzinga

What's Going On With Apple Stock Today?

Apple Inc (NASDAQ: AAPL) shares are trading flat on average volume Wednesday morning. The stock recorded gains in the previous 10 trading sessions, marking the longest winning streak for Apple since 2003.

Benzinga

Five Below Clocks 16% Top-Line Growth In Q4; Provides Q1, FY22 Outlook Below Consensus

Five Below Inc (NASDAQ:FIVE) reported fourth-quarter FY21 sales growth of 16.1% year-on-year, to $996.33 million, missing the consensus of $1.01 billion. Comparable sales increased by 3.4% versus last year. The gross profit rose by 16.4% Y/Y to $396.8 million with a margin of 39.8%. The operating margin was 18.8%, and operating income for…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

IM Cannabis Closes Acquisition Of Israel's Medical Marijuana Oranim Pharm

IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC) has completed the strategic acquisition of 51% of the rights in Oranim Pharm partnership, a pharmacy selling medical cannabis in Israel. The acquisition was completed through IMC Holdings Ltd., a wholly-owned subsidiary of IM Cannabis Corp., following receipt of all requisite approvals, including from the Israeli Medical…

Benzinga

Check Out What Whales Are Doing With LULU

Someone with a lot of money to spend has taken a bullish stance on Lululemon Athletica (NASDAQ:LULU). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Looking At Apple's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bearish stance on Apple. Looking at options history for Apple (NASDAQ:AAPL) we detected 85 strange trades.

Benzinga

Pro Traders React To Robinhood Extending Trading Hours: 'Caveat Emptor'

Shares of Robinhood Markets Inc (NASDAQ: HOOD) soared 24.2% on Tuesday after the popular stock trading app announced an extension of trading hours fo

Benzinga

Celsion's Earnings Outlook

Celsion (NASDAQ:CLSN) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Celsion will report an earnings per share (EPS) of $-0.90.

Benzinga

Earnings Outlook For Aehr Test Systems

Aehr Test Systems (NASDAQ:AEHR) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Aehr Test Systems will report an earnings per share (EPS) of $0.14.

Benzinga

Earnings Preview: Chicken Soup for the Soul

Chicken Soup for the Soul (NASDAQ:CSSE) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Chicken Soup for the Soul will report an earnings per share (EPS) of $-0.51.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Earnings Outlook For Acacia Research

Acacia Research (NASDAQ:ACTG) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Acacia Research will report an earnings per share (EPS) of $-0.04.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022

Upgrades

Benzinga

Earnings Outlook For Affimed

Affimed (NASDAQ:AFMD) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Affimed will report an earnings per share (EPS) of $-0.17.

Benzinga

Analyst Ratings For 1Life Healthcare

1Life Healthcare (NASDAQ:ONEM) has observed the following analyst ratings within the last quarter:

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

A Preview Of Arco Platform's Earnings

Arco Platform (NASDAQ:ARCE) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Arco Platform will report an earnings per share (EPS) of $0.31.

Benzinga

Preview: Calithera Biosciences's Earnings

Calithera Biosciences (NASDAQ:CALA) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Calithera Biosciences will report an earnings per share (EPS) of $-0.24.

Benzinga

Earnings Outlook For Biocept

Biocept (NASDAQ:BIOC) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Biocept will report an earnings per share (EPS) of $-0.19.

Benzinga

Earnings Preview: Dare Bioscience

Dare Bioscience (NASDAQ:DARE) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Dare Bioscience will report an earnings per share (EPS) of $-0.15.

Benzinga

Analyst Ratings For PepsiCo

Analysts have provided the following ratings for PepsiCo (NASDAQ:PEP) within the last quarter:

Benzinga

What 4 Analyst Ratings Have To Say About Academy Sports

Over the past 3 months, 4 analysts have published their opinion on Academy Sports (NASDAQ:ASO) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Peering Into Adagio Therapeutics Inc. - Common Stock's Recent Short Interest

Adagio Therapeutics Inc. - Common Stock's (NASDAQ:ADGI) short percent of float has fallen 11.69% since its last report. The company recently reported that it has 5.28 million shares sold short, which is 12.92% of all regular shares that are available for trading.

1 … 758 759 760 761

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.